Skip to content

Incyte INCY Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Pfizer logo
PfizerPFE
$159.73B+11.1%
Gilead Sciences logo
Gilead SciencesGILD
$172.99B+23.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$588.76B+47.3%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Biogen logo
BiogenBIIB
$26.91B+34.3%

Other financials

Income statement

See full
Revenue$1.3B+20.9%
Gross profit$1.2B+19.2%
Operating income$301.1M+46.8%
Net income$303.3M+91.7%
EPS (diluted)$1.47+83.8%

Balance sheet

See full
Cash & equivalents$3.5B+78.2%
Total debt$39.4M-8.6%
Total equity$5.6B+53.3%
Total assets$7.3B+27.7%

Cash flow

See full
Operating cash flow$369.4M+38.8%
CapEx$1.6M-43.5%
Free cash flow$367.7M+39.7%

Valuation

See full
Enterprise value$16.35B+55.9%
P/E13.8×-568×
P/S3.7×+0.9×

Profitability

See full
Gross margin92.5%-0.2pp
Operating margin30%+26.1pp
Net margin26.7%+26.2pp

Returns & leverage

See full
Return on equity30.8%+30.4pp
Debt / equity0.0×
Current ratio3.7×+1.6×

Where this comes from

Computed from the period-end share price: $18.73B.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's market capitalization?
Incyte (INCY) reported market capitalization of $18.73B in Q1 2026.
How has Incyte's market capitalization changed year-over-year?
Incyte's market capitalization increased by 59.9% year-over-year, from $11.72B to $18.73B.
What is the long-term trend for Incyte's market capitalization?
Over 4 years (2021 to 2025), Incyte's market capitalization has grown at a -2.6% compound annual growth rate (CAGR), from $67.94B to $61.03B.
What does market capitalization mean?
What the stock market says the company's equity is worth.
How do you interpret market capitalization?
A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
How does market capitalization compare across companies?
Comparable across companies as a size class; the input to every equity-price valuation multiple.